CXCL16 participates in pathogenesis of immunological liver injury by regulating T lymphocyte infiltration in liver tissue

Figure 6 Protective effect of anti-CXCL16 antibody on survival rate for murine lethal hepatic failure. Immunological liver injury was induced by BCG and LPS treatment and anti-CXCL16 Ab (solid line, n = 10) or control Ab (dashed line, n = 10) was injected as indicated in Materials and methods. The anti-CXCL16 antibody significantly protected the mice from lethality (^bP<0.01 vs control Ab).